Gilead Sciences (GILD) Financials

$151.00

$-0.23 (-0.15%)

As on 04-Sep-2026 16:43EDT

Market cap

$187,227 Mln

Revenue (TTM)

$30,456 Mln

P/E Ratio

17.7

P/B Ratio

15.7

Div. Yield

2.1 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	30,456.00	29,442.00	28,754.00	27,116.00	27,281.00	27,305.00
Cost of Revenue	6,217.00	6,234.00	6,251.00	5,804.00	5,657.00	6,601.00
Gross Profit	24,239.00	23,208.00	22,503.00	27,116.00	21,624.00	20,704.00
Operating Expenses	25,732.00	11,507.00	20,841.00	11,808.00	14,294.00	10,786.00
Operating Profit (EBIT)	-1,387.00	11,701.00	1,662.00	7,605.00	7,330.00	9,918.00
Other Income	--	--	--	--	-581.00	-639.00
Profit before Tax	-1,955.00	9,796.00	690.00	6,859.00	5,814.00	8,278.00
Provision for Tax	1,285.00	1,286.00	211.00	-1,247.00	1,248.00	2,077.00
Profit after Tax (Net Income)	-3,240.00	8,510.00	480.00	5,665.00	4,592.00	6,225.00
Minority Interest	--	--	--	47.00	26.00	24.00
Consolidated Profit	--	--	--	--	4,592.00	6,225.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	11,828.00	22,702.00	19,330.00	22,833.00	21,240.00	21,069.00
Minority Interest	--	--	--	-84.00	-31.00	-5.00
Non-Current Liabilities	26,598.00	24,592.00	27,745.00	28,096.00	30,724.00	35,278.00
Current Liabilities	11,020.00	11,813.00	12,004.00	11,280.00	11,238.00	11,610.00
Total Liabilities	60,382.00	59,023.00	58,995.00	62,125.00	63,171.00	67,952.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	35,418.00	40,681.00	39,823.00	46,040.00	48,727.00	53,180.00
Current Assets	13,945.00	18,342.00	19,173.00	16,085.00	14,443.00	14,772.00
Total Assets	60,382.00	59,023.00	58,995.00	62,125.00	63,171.00	67,952.00
Total Debt*	26,246.00	24,936.00	26,711.00	24,987.00	25,230.00	26,695.00
Net Current Assets	2,925.00	6,529.00	7,169.00	4,805.00	3,990.00	3,446.00

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	10,019.00	10,828.00	8,006.00	9,072.00	11,384.00
Cash Flow from Investing Activities	--	-4,793.00	-3,449.00	-2,265.00	-2,466.00	-3,131.00
Cash from Financing Activities	--	-7,745.00	-3,433.00	-5,125.00	-6,469.00	-8,877.00
Net Cash Inflow / Outflow	--	--	--	--	137.00	-624.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	-2.66	6.79	0.38	4.51	3.63	4.93
Cash EPS ($)	--	8.99	2.58	6.53	5.30	6.56
Adjusted Book Value ($)	--	18.12	15.35	18.18	16.80	16.69
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	8.00	8.60	6.37	7.18	9.02
Free Cash Flow per Share ($)	--	7.55	8.19	5.91	6.60	8.56

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	18.17	1.02	12.02	9.75	12.79
ROE (%)	-18.77	40.49	2.28	25.71	21.71	31.70
ROA (%)	-5.09	14.42	0.79	9.04	7.00	9.13
EBIT Margin (%)	29.71	36.75	5.80	28.05	24.74	33.98
Net Margin (%)	-10.64	28.90	1.67	20.89	17.20	23.34
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	5.52	0.02	0.06	-0.01	0.00	0.11
EBIT Growth (%)	10.34	549.07	-78.08	12.68	-27.27	249.75
Net Profit Growth (%)	-151.34	1,672.92	-91.53	23.37	-26.23	4,960.98
EPS Growth (%)	-152.90	16.81	-0.92	0.24	-0.26	49.49
Book Value Growth (%)	-39.30	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	17.74	18.07	242.28	17.96	23.63	14.72
Price / Book Value	15.68	6.77	6.02	4.46	5.11	4.35
Dividend Yield (%)	2.13	--	--	--	--	--
EV/EBITDA	115.68	12.45	29.64	15.71	14.39	9.87
Close Price ($)	126.34	122.74	92.37	81.01	85.85	72.61
High Price ($)	157.29	128.70	98.90	88.29	89.74	74.12
Low Price ($)	107.75	88.57	62.07	72.87	57.17	57.93
Market Cap ($ Cr)	187,227.03	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	2.01	1.10	1.38	1.09	1.19	1.27
Short term debt to equity ratio	0.20	0.12	0.09	0.08	0.11	0.07
Current Ratio	1.27	1.55	1.60	1.43	1.29	1.27
Quick Ratio	1.09	1.40	1.45	1.27	1.15	1.13
Interest Coverage	-0.96	10.57	1.71	8.06	7.22	9.27

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	16.60	16.69	15.37	17.19	17.51	16.45
Asset Turnover	0.48	0.50	0.47	0.43	0.42	0.40
Receivable days	--	57.89	57.67	63.56	62.06	62.77
Inventory Days	--	102.06	102.17	103.65	100.88	91.33
Payable days	--	45.35	40.40	45.78	51.98	42.86
Cash Conversion Cycle	--	114.61	119.43	121.42	110.96	111.24

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)